Revenues in USD of Centessa Pharmaceuticals plc from 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Centessa Pharmaceuticals plc quarterly/annual Revenues history and change rate from 2022 to Q3 2025.
  • Centessa Pharmaceuticals plc Revenues for the quarter ending September 30, 2025 was $0.000.
  • Centessa Pharmaceuticals plc Revenues for the twelve months ending September 30, 2025 was $15M.
  • Centessa Pharmaceuticals plc annual Revenues for 2024 was $0.000, a 100% decline from 2023.
  • Centessa Pharmaceuticals plc annual Revenues for 2023 was $6.85M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Centessa Pharmaceuticals plc Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $15M $0 $0 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $15M $0 $0 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $15M $15M +$15M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $0 $0 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-24
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14

Centessa Pharmaceuticals plc Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 -$6.85M -100% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $6.85M +$6.85M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.